Nerve Repair & Regeneration Market by Product (Neuromodulation devices, Conduit, Wrap, Protector, Grafts), Procedure (Nerve Repair [Epineural, Perineural], Grafting [Allograft, Xenograft]), Application, End User, No. of Devices – Global Forecast to 2031
The nerve repair & regeneration market is projected to grow from USD 8.06 billion in 2026 to USD 12.64 billion by 2031, at a CAGR of 9.42%. The increasing incidence of traumatic nerve injuries, peripheral nerve damage, and neurological disorders is driving demand for effective nerve repair and functional restoration solutions. As surgical and regenerative approaches continue to advance, the need for innovative nerve grafts, conduits, biomaterials, and neurostimulation technologies is expanding across hospitals and specialty care settings. Furthermore, advancements in tissue engineering, bioengineered scaffolds, nerve regeneration techniques, and minimally invasive procedures are improving treatment outcomes and supporting faster functional recovery. These innovations enable healthcare providers to address complex nerve injuries more effectively, supporting growth in the nerve repair & regeneration market.
“The Neurostimulation and Neuromodulation segment is expected to account for the largest share of the nerve repair and regeneration market, by procedure.”
Based on procedure, the nerve repair and regeneration market is segmented into neurostimulation & neuromodulation and nerve repair & regeneration. The neurostimulation & neuromodulation segment accounts for the largest market share because stimulation-based therapies are established for managing chronic pain, neurological disorders, and nerve-related conditions. These technologies provide targeted therapeutic interventions through electrical stimulation of nerves or neural pathways, supporting symptom management and improved patient outcomes. Additionally, the increasing adoption of implantable and non-invasive stimulation systems, growing availability of advanced neuromodulation technologies, and expanding clinical applications continue to support demand for these procedures, making neurostimulation and neuromodulation the largest segment within the market.“The Hospitals and Ambulatory Surgical Centers segment is expected to account for the largest share of the nerve repair and regeneration market.”
The global nerve repair and regeneration market can be segmented by end user into hospitals and ambulatory surgical centers (ASCs), specialty clinics, and other end users. Among these, the hospitals and ASCs segment accounted for the largest market share. Hospitals and ASCs remain the primary settings for nerve repair, reconstructive procedures, and neurostimulation interventions due to the availability of specialized surgical teams, advanced operating facilities, and comprehensive postoperative care. Furthermore, the increasing adoption of specialized nerve treatment procedures, the availability of advanced surgical equipment, and the growing preference for outpatient interventions are expected to support continued use of nerve repair and regeneration solutions across hospitals and ASCs worldwide.“Asia Pacific: The fastest-growing market for nerve repair and regeneration from 2026 to 2031”
The global nerve repair and regeneration market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is projected to grow at the highest regional CAGR from 2026 to 2031. The region is witnessing increasing demand for advanced neurological and reconstructive procedures, supported by improvements in specialized healthcare services and surgical capabilities. China is expanding access to advanced medical technologies through healthcare infrastructure development and increasing investments in specialized neurological care. India's growing network of tertiary-care hospitals, specialty clinics, and surgical centers is supporting the adoption of nerve repair, regeneration, and neuromodulation technologies. Meanwhile, Japan's aging population and increasing demand for neurological and pain management therapies continue to support the expansion of the nerve repair and regeneration market across the region. The breakdown of the profile of primary participants in the nerve repair and regeneration market:- By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
- By Designation: C-level Executives - 27%, Directors – 18%, and Others - 55%
- By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and Middle East & Africa - 4%
Research Coverage
This research report categorizes the nerve repair and regeneration market by product (neurostimulation & neuromodulation, biomaterial-based products), by procedure (neurostimulation & neuromodulation and nerve repair & regeneration), by application (peripheral nerve injuries, spinal cord injuries, neuropathic pain, neurodegenerative disorders, cranial nerve disorders, urological & pelvic nerve disorders, orthopedic & sports-related nerve injuries and other applications), by end user (hospitals & ASCs, specialty clinics, other end users), and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The report covers detailed information on major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the nerve repair and regeneration market. A detailed analysis of key industry players provides insights into their business overview, solutions, key strategies such as acquisitions, agreements, and product launches, and recent developments in the nerve repair and regeneration market. This report covers a competitive analysis of upcoming startups in the nerve repair and regeneration market ecosystem.Reasons to buy this report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall repair and regeneration market and the subsegments. This report will help stakeholders understand the competitive landscape and gain insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, opportunities, and challenges.The report provides insights on the following pointers
- Analysis of key drivers (rising prevalence of neurological disorders and nerve injuries, rising geriatric population and the subsequent increase in the prevalence of neurological disorders, favorable government support and funding with advanced healthcare infrastructure, development of advanced neuromodulation and neurostimulation technologies), restraints (preference for drug therapies over neuromodulation products), opportunities (large patient population and rising healthcare investments in emerging economies, expanding clinical applications of nerve repair and regeneration technologies), and challenges (stringent regulatory framework and time-consuming approval processes for nerve repair and regeneration products, shortage of trained professionals) influencing the growth of the nerve repair and regeneration market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the nerve repair and regeneration market
- Market Development: Comprehensive information about lucrative markets—the report analyzes the nerve repair and regeneration market across varied regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the nerve repair and regeneration market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as Medtronic plc (Ireland), Boston Scientific Corporation (US), Axogen Corporation (US), Baxter (US), Integra LifeSciences Corporation (US), NeuroPace, Inc. (US), Bioventus Inc. (US), Abbott Laboratories (US), LivaNova PLC (UK), and Neuronetics, Inc. (US)
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 NERVE REPAIR & REGENERATION MARKET OVERVIEW
3.2 NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2026 VS. 2031
3.3 NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2026 VS. 2031
3.4 NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2026 VS. 2031
3.5 NERVE REPAIR & REGENERATION MARKET, BY END USER, 2026 VS. 2031
3.6 NERVE REPAIR & REGENERATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Rising prevalence of neurological disorders and nerve injuries
4.2.1.2 Rising geriatric population and subsequent increase in prevalence of neurological disorders
4.2.1.3 Favorable government support and funding with advanced healthcare infrastructure
4.2.1.4 Development of advanced neuromodulation and neurostimulation technologies
4.2.2 RESTRAINTS
4.2.2.1 Preference for drug therapies over neuromodulation products
4.2.3 OPPORTUNITIES
4.2.3.1 Large patient population and rising healthcare investments in emerging economies
4.2.3.2 Expanding clinical applications of nerve repair & regeneration technologies
4.2.4 CHALLENGES
4.2.4.1 Stringent regulatory framework and time-consuming approval processes for nerve repair & regeneration products
4.2.4.2 Shortage of trained professionals
4.3 UNMET NEEDS & WHITE SPACES
4.3.1 UNMET NEEDS
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 BARGAINING POWER OF SUPPLIERS
5.1.2 BARGAINING POWER OF BUYERS
5.1.3 THREAT OF NEW ENTRANTS
5.1.4 THREAT OF SUBSTITUTES
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC INDICATORS
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS & FORECAST
5.3 SUPPLY CHAIN ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.6 PRICING ANALYSIS
5.6.1 AVERAGE SELLING PRICE TREND OF NERVE REPAIR & REGENERATION PRODUCTS, BY KEY PLAYER, 2024–2026
5.6.2 AVERAGE SELLING PRICE TREND OF NERVE REPAIR & REGENERATION PRODUCTS, BY REGION, 2024–2026
5.7 TRADE ANALYSIS
5.7.1 IMPORT SCENARIO (HS CODE 901890)
5.7.2 EXPORT SCENARIO (HS CODE 901890)
5.8 KEY CONFERENCES & EVENTS, 2026–2027
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10 INVESTMENT & FUNDING SCENARIO
5.11 CASE STUDY ANALYSIS
5.11.1 USE OF NEURAL MODULATION TECHNOLOGIES IN RESEARCH, CLINICAL PRACTICE, AND CONSUMER APPLICATIONS
5.11.2 PAIRING TRANSLINGUAL NEUROSTIMULATION WITH INTENSIVE REHABILITATION TO ENHANCE NEUROPLASTICITY AND IMPROVE MOTOR RECOVERY IN SEVERE TRAUMATIC BRAIN INJURY PATIENTS
5.11.3 APPLICATION OF NEUROMODULATION TECHNIQUES—FROM NON-INVASIVE BRAIN STIMULATION TO DEEP BRAIN STIMULATION
5.12 IMPACT OF 2025 US TARIFFS ON NERVE REPAIR & REGENERATION MARKET
5.12.1 INTRODUCTION
5.12.2 KEY TARIFF RATES
5.12.3 PRICE IMPACT ANALYSIS
5.12.4 IMPACT ON REGION
5.12.4.1 North America
5.12.4.2 Europe
5.12.4.3 Asia Pacific
5.12.5 IMPACT ON END-USE INDUSTRIES
5.12.5.1 Hospitals & ASCs
5.12.5.2 Specialty clinics
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 KEY EMERGING TECHNOLOGIES
6.1.1 NEUROSTIMULATION & NEUROMODULATION DEVICES
6.1.2 NERVE GRAFTS
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 WEARABLE BIOSENSORS
6.3 ADJACENT TECHNOLOGIES
6.3.1 REGENERATIVE MEDICINE & STEM CELLS
6.4 TECHNOLOGY/PRODUCT ROADMAP
6.4.1 SHORT-TERM (2025–2027) | OPTIMIZATION & STANDARDIZATION OF CORE NERVE REPAIR & REGENERATION TECHNOLOGIES
6.4.1.1 Core technology development
6.4.1.2 Product innovations
6.4.1.3 Market adoption
6.4.2 MID-TERM (2027–2030) | EXPANDED CAPABILITIES & SUSTAINABILITY
6.4.2.1 Advanced technology development
6.4.2.2 Product innovations
6.4.2.3 Market adoption
6.4.3 LONG-TERM (2030–2035+) | HIGH-PERFORMANCE & SUSTAINABLE NERVE REPAIR & REGENERATION TECHNOLOGIES
6.4.3.1 High-performance & integrated workflows
6.4.3.2 Product innovations
6.4.3.3 Market adoption
6.5 PATENT ANALYSIS
6.5.1 LIST OF MAJOR PATENTS
6.6 FUTURE APPLICATIONS
6.7 IMPACT OF AI/GENERATIVE AI ON NERVE REPAIR & REGENERATION MARKET
6.7.1 INTRODUCTION
6.7.2 TOP USE CASES & MARKET POTENTIAL
6.7.3 KEY COMPANIES IMPLEMENTING AI
6.7.4 FUTURE OF AI
7 SUSTAINABILITY & REGULATORY LANDSCAPE
7.1 REGIONAL REGULATIONS & COMPLIANCE
7.1.1 REGULATORY ANALYSIS
7.1.1.1 North America
7.1.1.1.1 US
7.1.1.1.2 Canada
7.1.1.2 Europe
7.1.1.3 Asia Pacific
7.1.1.3.1 China
7.1.1.3.2 Japan
7.1.1.3.3 India
7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2 SUSTAINABILITY INITIATIVES
7.2.1 ENVIRONMENTAL IMPACT & ECO-FRIENDLY INITIATIVES IN NERVE REPAIR & REGENERATION MARKET
7.2.1.1 Eco-friendly Initiatives
7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 BUYING CRITERIA
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
8.5 MARKET PROFITABILITY
8.5.1 REVENUE POTENTIAL
8.5.2 COST DYNAMICS
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS
9 NERVE REPAIR & REGENERATION MARKET, BY PRODUCT
9.1 INTRODUCTION
9.2 NEUROSTIMULATION & NEUROMODULATION DEVICES
9.2.1 SPINAL CORD STIMULATION DEVICES
9.2.1.1 Growing incidence of spinal cord injuries to fuel market growth
9.2.2 DEEP BRAIN STIMULATION DEVICES
9.2.2.1 Growing rates of Parkinson’s disease to highlight strong market potential of DBS
9.2.3 VAGUS NERVE STIMULATION DEVICES
9.2.3.1 Rising incidence of epilepsy to drive adoption of next-generation vagus nerve stimulation therapy
9.2.4 SACRAL NERVE STIMULATION DEVICES
9.2.4.1 Increasing prevalence of chronic urinary incontinence among elderly women to propel market growth
9.2.5 GASTRIC ELECTRICAL STIMULATION DEVICES
9.2.5.1 Increasing prevalence of gastroesophageal reflux disease and gastroparesis to fuel market growth
9.2.6 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES
9.2.6.1 Low cost and ease of use to fuel adoption in healthcare sector
9.2.7 TRANSCRANIAL MAGNETIC STIMULATION DEVICES
9.2.7.1 Minimal patient discomfort associated with transcranial magnetic stimulation to support demand
9.2.8 RESPIRATORY ELECTRICAL STIMULATION DEVICES
9.2.8.1 High treatment efficacy and increased focus on minimally invasive spinal cord treatment to fuel market growth
9.2.9 OTHER STIMULATION DEVICES
9.3 BIOMATERIALS
9.3.1 NERVE CONDUITS
9.3.1.1 Increasing research in field of nerve repair to support segment growth
9.3.2 NERVE GRAFTS
9.3.2.1 Advances in regenerative technologies and increasing complex nerve injuries to drive demand for effective nerve gap repair solutions
9.3.3 NERVE WRAPS
9.3.3.1 Increasing incidence of peripheral injuries to drive growth
9.3.4 NERVE PROTECTORS
9.3.4.1 Increasing focus on reducing postoperative scarring and protecting repaired nerves to drive adoption of nerve protection solutions
10 NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES: VOLUME ANALYSIS (NUMBER OF DEVICES)
11 NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE
11.1 INTRODUCTION
11.2 NEUROSTIMULATION & NEUROMODULATION
11.2.1 INTERNAL NEUROSTIMULATION & NEUROMODULATION
11.2.1.1 Minimally invasive nature and reversibility to support growth of this segment
11.2.2 EXTERNAL NEUROSTIMULATION & NEUROMODULATION
11.2.2.1 Rising number of noninvasive procedures to ensure growth
11.3 NERVE REPAIR & REGENERATION
11.3.1 DIRECT NERVE REPAIR/NEURORRHAPHY
11.3.1.1 Epineural repair
11.3.1.1.1 Short operating times, ease, and minimal suturing requirements to drive growth
11.3.1.2 Perineural repair
11.3.1.2.1 High complexity of perineural repair surgery to affect market prospects
11.3.1.3 Group fascicular repair
11.3.1.3.1 Long procedural time to restrain growth
11.3.2 NERVE GRAFTING
11.3.2.1 Allografts
11.3.2.1.1 Benefits of allografts over autograft usage to drive growth
11.3.2.2 Xenografts
11.3.2.2.1 Need for immunosuppression associated with xenograft use to restrain growth
11.3.3 NERVE GUIDANCE & PROTECTION PROCEDURES
11.3.3.1 Advances in nerve grafts, conduits, biomaterials, and regenerative technologies to drive market demand
12 NERVE REPAIR & REGENERATION MARKET, BY APPLICATION
12.1 INTRODUCTION
12.2 PERIPHERAL NERVE INJURIES
12.2.1 RISING BURDEN OF PERIPHERAL NERVE INJURIES TO ACCELERATE DEMAND FOR NERVE REPAIR & REGENERATION
12.3 SPINAL CORD INJURIES
12.3.1 SUBSTANTIAL AND PERSISTENT DISABILITY ASSOCIATED WITH SCI TO SUPPORT DEMAND FOR NERVE REPAIR & REGENERATION
12.4 NEUROPATHIC PAIN
12.4.1 CONTINUING NEED FOR EFFECTIVE LONG-TERM SYMPTOM MANAGEMENT TO SUPPORT DEMAND FOR NERVE REPAIR & REGENERATION
12.5 NEURODEGENERATIVE DISORDERS
12.5.1 GROWING PATIENT POPULATION WITH NEURODEGENERATIVE DISORDERS TO BOOST DEMAND FOR ADVANCED THERAPIES
12.6 CRANIAL NERVE DISORDERS
12.6.1 ADVANCES IN CRANIAL NERVE DISORDER MANAGEMENT TO CREATE GROWTH OPPORTUNITIES
12.7 UROLOGICAL & PELVIC NERVE DISORDERS
12.7.1 INCREASING AWARENESS OF NERVE-BASED TREATMENT APPROACHES TO ACCELERATE ADOPTION
12.8 ORTHOPEDIC & SPORTS-RELATED NERVE INJURIES
12.8.1 GROWING PARTICIPATION IN SPORTS AND PHYSICAL ACTIVITIES TO FUEL DEMAND FOR NERVE REPAIR SOLUTIONS
12.9 OTHER APPLICATIONS
13 NERVE REPAIR & REGENERATION MARKET, BY END USER
13.1 INTRODUCTION
13.2 HOSPITALS & AMBULATORY SURGICAL CENTERS
13.2.1 ADVANCED INFRASTRUCTURE AND ABILITY TO MANAGE COMPLEX NEUROLOGICAL CASES TO PROPEL MARKET GROWTH
13.3 SPECIALTY CLINICS
13.3.1 NEED FOR FOCUSED EXPERTISE AND BETTER REHABILITATION MANAGEMENT TO ACCELERATE MARKET EXPANSION
13.4 OTHER END USERS
14 NERVE REPAIR & REGENERATION MARKET, BY REGION
14.1 INTRODUCTION
14.2 NORTH AMERICA
14.2.1 US
14.2.1.1 US to dominate North American nerve repair & regeneration market during forecast period
14.2.2 CANADA
14.2.2.1 Increasing neurological disorder rates and rising government funding to propel market growth
14.3 EUROPE
14.3.1 GERMANY
14.3.1.1 Favorable government initiatives to boost market
14.3.2 UK
14.3.2.1 Increased public & private sector healthcare expenditure and investments to fuel market growth
14.3.3 FRANCE
14.3.3.1 Favorable healthcare reforms to drive adoption of advanced neuromodulation techniques
14.3.4 ITALY
14.3.4.1 Rising cases of dementia and Alzheimer’s among geriatric population to spur market growth
14.3.5 SPAIN
14.3.5.1 Growing geriatric population and subsequent increase in incidence of neurological disorders to drive market growth
14.3.6 REST OF EUROPE
14.4 ASIA PACIFIC
14.4.1 CHINA
14.4.1.1 Increasing focus on healthcare infrastructure to boost market
14.4.2 JAPAN
14.4.2.1 Established healthcare system to fuel market
14.4.3 INDIA
14.4.3.1 Presence of large patient pool and rapidly growing healthcare sector to drive market
14.4.4 REST OF ASIA PACIFIC
14.5 LATIN AMERICA
14.5.1 INCREASING OCCURRENCE OF NEUROLOGICAL DISORDERS ACROSS REGION TO SUPPORT GROWTH
14.6 MIDDLE EAST & AFRICA
14.6.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE AND INCREASED INVESTMENTS FROM GLOBAL AND REGIONAL MARKET PLAYERS TO FUEL GROWTH
15 COMPETITIVE LANDSCAPE
15.1 INTRODUCTION
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
15.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN NERVE REPAIR & REGENERATION MARKET
15.3 REVENUE ANALYSIS, 2023–2025
15.4 MARKET SHARE ANALYSIS, 2025
15.4.1 GLOBAL MARKET SHARE ANALYSIS, 2025
15.4.2 US MARKET SHARE ANALYSIS, 2025
15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
15.5.1 STARS
15.5.2 EMERGING LEADERS
15.5.3 PERVASIVE PLAYERS
15.5.4 PARTICIPANTS
15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
15.5.5.1 Company footprint
15.5.5.2 Region footprint
15.5.5.3 Product footprint
15.5.5.4 Procedure footprint
15.5.5.5 End-user footprint
15.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
15.6.1 PROGRESSIVE COMPANIES
15.6.2 RESPONSIVE COMPANIES
15.6.3 DYNAMIC COMPANIES
15.6.4 STARTING BLOCKS
15.6.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
15.6.5.1 Detailed list of key startups/SMEs
15.6.5.1.1 Competitive benchmarking of startups/SMEs (1/2)
15.6.5.1.2 Competitive benchmarking of startups/SMEs (2/2)
15.7 COMPANY VALUATION & FINANCIAL METRICS
15.7.1 FINANCIAL METRICS
15.7.2 COMPANY VALUATION
15.8 BRAND/PRODUCT COMPARISON
15.9 COMPETITIVE SCENARIO
15.9.1 PRODUCT LAUNCHES & APPROVALS
15.9.2 DEALS
16 COMPANY PROFILES
16.1 KEY PLAYERS
16.1.1 MEDTRONIC
16.1.1.1 Business overview
16.1.1.2 Products offered
16.1.1.3 Recent developments
16.1.1.3.1 Product approvals
16.1.1.3.2 Deals
16.1.1.4 MnM view
16.1.1.4.1 Right to win
16.1.1.4.2 Strategic choices
16.1.1.4.3 Weaknesses & competitive threats
16.1.2 BOSTON SCIENTIFIC CORPORATION
16.1.2.1 Business overview
16.1.2.2 Products offered
16.1.2.3 Recent developments
16.1.2.3.1 Product approvals
16.1.2.3.2 Deals
16.1.2.4 MnM view
16.1.2.4.1 Right to win
16.1.2.4.2 Strategic choices
16.1.2.4.3 Weaknesses & competitive threats
16.1.3 ABBOTT
16.1.3.1 Business overview
16.1.3.2 Products offered
16.1.3.3 Recent developments
16.1.3.3.1 Product approvals
16.1.3.4 MnM view
16.1.3.4.1 Right to win
16.1.3.4.2 Strategic choices
16.1.3.4.3 Weaknesses & competitive threats
16.1.4 LIVANOVA PLC
16.1.4.1 Business overview
16.1.4.2 Products offered
16.1.4.3 Recent developments
16.1.4.3.1 Product launches
16.1.4.4 MnM view
16.1.4.4.1 Right to win
16.1.4.4.2 Strategic choices
16.1.4.4.3 Weaknesses & competitive threats
16.1.5 AXOGEN CORPORATION
16.1.5.1 Business overview
16.1.5.2 Products offered
16.1.5.3 Recent developments
16.1.5.3.1 Product launches
16.1.5.4 MnM view
16.1.5.4.1 Right to win
16.1.5.4.2 Strategic choices
16.1.5.4.3 Weaknesses & competitive threats
16.1.6 NEUROPACE, INC.
16.1.6.1 Business overview
16.1.6.2 Products offered
16.1.7 BIOVENTUS
16.1.7.1 Business overview
16.1.7.2 Products offered
16.1.7.3 Recent developments
16.1.7.3.1 Product approvals
16.1.8 BAXTER
16.1.8.1 Business overview
16.1.8.2 Products offered
16.1.8.3 Recent developments
16.1.8.3.1 Deals
16.1.9 NEURONETICS
16.1.9.1 Business overview
16.1.9.2 Products offered
16.1.9.3 Recent developments
16.1.9.3.1 Product launches & approvals
16.1.9.3.2 Deals
16.1.10 INTEGRA LIFESCIENCES
16.1.10.1 Business overview
16.1.10.2 Products offered
16.1.11 ELECTROCORE, INC.
16.1.11.1 Business overview
16.1.11.2 Products offered
16.1.11.3 Recent developments
16.1.11.3.1 Product launches
16.1.11.3.2 Deals
16.2 OTHER PLAYERS
16.2.1 NEUROSIGMA, INC.
16.2.2 SOTERIX MEDICAL INC.
16.2.3 SYNAPSE BIOMEDICAL INC.
16.2.4 ALEVA NEUROTHERAPEUTICS
16.2.5 THERANICA BIO-ELECTRONICS LTD.
16.2.6 GIMER MEDICAL
16.2.7 REGENITY BIOSCIENCES
16.2.8 CHECKPOINT SURGICAL, INC.
16.2.9 RENISHAW PLC
16.2.10 TVNS TECHNOLOGIES GMBH
16.2.11 BIOWAVE
16.2.12 BIOTRONIK
16.2.13 SALUDA MEDICAL PTY LTD.
16.2.14 ALAFAIR BIOSCIENCES, INC.
17 RESEARCH METHODOLOGY
17.1 RESEARCH DATA
17.1.1 SECONDARY DATA
17.1.1.1 List of secondary sources
17.1.1.2 Key data from secondary sources
17.1.2 PRIMARY DATA
17.1.2.1 List of primary sources
17.1.2.2 Key data from primary sources
17.1.2.3 Key industry insights
17.1.2.4 Breakdown of primary interviews
17.2 MARKET SIZE ESTIMATION
17.2.1 TOTAL MARKET SIZE: NERVE REPAIR & REGENERATIVE MARKET
17.2.2 BOTTOM-UP APPROACH
17.2.2.1 Approach 1: Revenue estimation of key players
17.2.2.2 Approach 2: Study of annual reports and investor presentations
17.2.2.3 Approach 3: Primary interviews
17.2.2.4 Growth forecast
17.2.2.5 CAGR projections
17.2.3 TOP-DOWN APPROACH
17.3 DATA TRIANGULATION
17.4 RESEARCH ASSUMPTIONS
17.4.1 STUDY-RELATED ASSUMPTIONS
17.5 STUDY ASSUMPTIONS
17.6 PARAMETRIC ASSUMPTIONS
17.7 RESEARCH LIMITATIONS
17.8 RISK ASSESSMENT
18 APPENDIX
18.1 DISCUSSION GUIDE
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
18.3 CUSTOMIZATION OPTIONS
18.4 RELATED REPORTS
18.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 NERVE REPAIR & REGENERATION MARKET OVERVIEW
3.2 NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2026 VS. 2031
3.3 NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2026 VS. 2031
3.4 NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2026 VS. 2031
3.5 NERVE REPAIR & REGENERATION MARKET, BY END USER, 2026 VS. 2031
3.6 NERVE REPAIR & REGENERATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Rising prevalence of neurological disorders and nerve injuries
4.2.1.2 Rising geriatric population and subsequent increase in prevalence of neurological disorders
4.2.1.3 Favorable government support and funding with advanced healthcare infrastructure
4.2.1.4 Development of advanced neuromodulation and neurostimulation technologies
4.2.2 RESTRAINTS
4.2.2.1 Preference for drug therapies over neuromodulation products
4.2.3 OPPORTUNITIES
4.2.3.1 Large patient population and rising healthcare investments in emerging economies
4.2.3.2 Expanding clinical applications of nerve repair & regeneration technologies
4.2.4 CHALLENGES
4.2.4.1 Stringent regulatory framework and time-consuming approval processes for nerve repair & regeneration products
4.2.4.2 Shortage of trained professionals
4.3 UNMET NEEDS & WHITE SPACES
4.3.1 UNMET NEEDS
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 BARGAINING POWER OF SUPPLIERS
5.1.2 BARGAINING POWER OF BUYERS
5.1.3 THREAT OF NEW ENTRANTS
5.1.4 THREAT OF SUBSTITUTES
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC INDICATORS
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS & FORECAST
5.3 SUPPLY CHAIN ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.6 PRICING ANALYSIS
5.6.1 AVERAGE SELLING PRICE TREND OF NERVE REPAIR & REGENERATION PRODUCTS, BY KEY PLAYER, 2024–2026
5.6.2 AVERAGE SELLING PRICE TREND OF NERVE REPAIR & REGENERATION PRODUCTS, BY REGION, 2024–2026
5.7 TRADE ANALYSIS
5.7.1 IMPORT SCENARIO (HS CODE 901890)
5.7.2 EXPORT SCENARIO (HS CODE 901890)
5.8 KEY CONFERENCES & EVENTS, 2026–2027
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10 INVESTMENT & FUNDING SCENARIO
5.11 CASE STUDY ANALYSIS
5.11.1 USE OF NEURAL MODULATION TECHNOLOGIES IN RESEARCH, CLINICAL PRACTICE, AND CONSUMER APPLICATIONS
5.11.2 PAIRING TRANSLINGUAL NEUROSTIMULATION WITH INTENSIVE REHABILITATION TO ENHANCE NEUROPLASTICITY AND IMPROVE MOTOR RECOVERY IN SEVERE TRAUMATIC BRAIN INJURY PATIENTS
5.11.3 APPLICATION OF NEUROMODULATION TECHNIQUES—FROM NON-INVASIVE BRAIN STIMULATION TO DEEP BRAIN STIMULATION
5.12 IMPACT OF 2025 US TARIFFS ON NERVE REPAIR & REGENERATION MARKET
5.12.1 INTRODUCTION
5.12.2 KEY TARIFF RATES
5.12.3 PRICE IMPACT ANALYSIS
5.12.4 IMPACT ON REGION
5.12.4.1 North America
5.12.4.2 Europe
5.12.4.3 Asia Pacific
5.12.5 IMPACT ON END-USE INDUSTRIES
5.12.5.1 Hospitals & ASCs
5.12.5.2 Specialty clinics
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 KEY EMERGING TECHNOLOGIES
6.1.1 NEUROSTIMULATION & NEUROMODULATION DEVICES
6.1.2 NERVE GRAFTS
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 WEARABLE BIOSENSORS
6.3 ADJACENT TECHNOLOGIES
6.3.1 REGENERATIVE MEDICINE & STEM CELLS
6.4 TECHNOLOGY/PRODUCT ROADMAP
6.4.1 SHORT-TERM (2025–2027) | OPTIMIZATION & STANDARDIZATION OF CORE NERVE REPAIR & REGENERATION TECHNOLOGIES
6.4.1.1 Core technology development
6.4.1.2 Product innovations
6.4.1.3 Market adoption
6.4.2 MID-TERM (2027–2030) | EXPANDED CAPABILITIES & SUSTAINABILITY
6.4.2.1 Advanced technology development
6.4.2.2 Product innovations
6.4.2.3 Market adoption
6.4.3 LONG-TERM (2030–2035+) | HIGH-PERFORMANCE & SUSTAINABLE NERVE REPAIR & REGENERATION TECHNOLOGIES
6.4.3.1 High-performance & integrated workflows
6.4.3.2 Product innovations
6.4.3.3 Market adoption
6.5 PATENT ANALYSIS
6.5.1 LIST OF MAJOR PATENTS
6.6 FUTURE APPLICATIONS
6.7 IMPACT OF AI/GENERATIVE AI ON NERVE REPAIR & REGENERATION MARKET
6.7.1 INTRODUCTION
6.7.2 TOP USE CASES & MARKET POTENTIAL
6.7.3 KEY COMPANIES IMPLEMENTING AI
6.7.4 FUTURE OF AI
7 SUSTAINABILITY & REGULATORY LANDSCAPE
7.1 REGIONAL REGULATIONS & COMPLIANCE
7.1.1 REGULATORY ANALYSIS
7.1.1.1 North America
7.1.1.1.1 US
7.1.1.1.2 Canada
7.1.1.2 Europe
7.1.1.3 Asia Pacific
7.1.1.3.1 China
7.1.1.3.2 Japan
7.1.1.3.3 India
7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2 SUSTAINABILITY INITIATIVES
7.2.1 ENVIRONMENTAL IMPACT & ECO-FRIENDLY INITIATIVES IN NERVE REPAIR & REGENERATION MARKET
7.2.1.1 Eco-friendly Initiatives
7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 BUYING CRITERIA
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
8.5 MARKET PROFITABILITY
8.5.1 REVENUE POTENTIAL
8.5.2 COST DYNAMICS
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS
9 NERVE REPAIR & REGENERATION MARKET, BY PRODUCT
9.1 INTRODUCTION
9.2 NEUROSTIMULATION & NEUROMODULATION DEVICES
9.2.1 SPINAL CORD STIMULATION DEVICES
9.2.1.1 Growing incidence of spinal cord injuries to fuel market growth
9.2.2 DEEP BRAIN STIMULATION DEVICES
9.2.2.1 Growing rates of Parkinson’s disease to highlight strong market potential of DBS
9.2.3 VAGUS NERVE STIMULATION DEVICES
9.2.3.1 Rising incidence of epilepsy to drive adoption of next-generation vagus nerve stimulation therapy
9.2.4 SACRAL NERVE STIMULATION DEVICES
9.2.4.1 Increasing prevalence of chronic urinary incontinence among elderly women to propel market growth
9.2.5 GASTRIC ELECTRICAL STIMULATION DEVICES
9.2.5.1 Increasing prevalence of gastroesophageal reflux disease and gastroparesis to fuel market growth
9.2.6 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES
9.2.6.1 Low cost and ease of use to fuel adoption in healthcare sector
9.2.7 TRANSCRANIAL MAGNETIC STIMULATION DEVICES
9.2.7.1 Minimal patient discomfort associated with transcranial magnetic stimulation to support demand
9.2.8 RESPIRATORY ELECTRICAL STIMULATION DEVICES
9.2.8.1 High treatment efficacy and increased focus on minimally invasive spinal cord treatment to fuel market growth
9.2.9 OTHER STIMULATION DEVICES
9.3 BIOMATERIALS
9.3.1 NERVE CONDUITS
9.3.1.1 Increasing research in field of nerve repair to support segment growth
9.3.2 NERVE GRAFTS
9.3.2.1 Advances in regenerative technologies and increasing complex nerve injuries to drive demand for effective nerve gap repair solutions
9.3.3 NERVE WRAPS
9.3.3.1 Increasing incidence of peripheral injuries to drive growth
9.3.4 NERVE PROTECTORS
9.3.4.1 Increasing focus on reducing postoperative scarring and protecting repaired nerves to drive adoption of nerve protection solutions
10 NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES: VOLUME ANALYSIS (NUMBER OF DEVICES)
11 NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE
11.1 INTRODUCTION
11.2 NEUROSTIMULATION & NEUROMODULATION
11.2.1 INTERNAL NEUROSTIMULATION & NEUROMODULATION
11.2.1.1 Minimally invasive nature and reversibility to support growth of this segment
11.2.2 EXTERNAL NEUROSTIMULATION & NEUROMODULATION
11.2.2.1 Rising number of noninvasive procedures to ensure growth
11.3 NERVE REPAIR & REGENERATION
11.3.1 DIRECT NERVE REPAIR/NEURORRHAPHY
11.3.1.1 Epineural repair
11.3.1.1.1 Short operating times, ease, and minimal suturing requirements to drive growth
11.3.1.2 Perineural repair
11.3.1.2.1 High complexity of perineural repair surgery to affect market prospects
11.3.1.3 Group fascicular repair
11.3.1.3.1 Long procedural time to restrain growth
11.3.2 NERVE GRAFTING
11.3.2.1 Allografts
11.3.2.1.1 Benefits of allografts over autograft usage to drive growth
11.3.2.2 Xenografts
11.3.2.2.1 Need for immunosuppression associated with xenograft use to restrain growth
11.3.3 NERVE GUIDANCE & PROTECTION PROCEDURES
11.3.3.1 Advances in nerve grafts, conduits, biomaterials, and regenerative technologies to drive market demand
12 NERVE REPAIR & REGENERATION MARKET, BY APPLICATION
12.1 INTRODUCTION
12.2 PERIPHERAL NERVE INJURIES
12.2.1 RISING BURDEN OF PERIPHERAL NERVE INJURIES TO ACCELERATE DEMAND FOR NERVE REPAIR & REGENERATION
12.3 SPINAL CORD INJURIES
12.3.1 SUBSTANTIAL AND PERSISTENT DISABILITY ASSOCIATED WITH SCI TO SUPPORT DEMAND FOR NERVE REPAIR & REGENERATION
12.4 NEUROPATHIC PAIN
12.4.1 CONTINUING NEED FOR EFFECTIVE LONG-TERM SYMPTOM MANAGEMENT TO SUPPORT DEMAND FOR NERVE REPAIR & REGENERATION
12.5 NEURODEGENERATIVE DISORDERS
12.5.1 GROWING PATIENT POPULATION WITH NEURODEGENERATIVE DISORDERS TO BOOST DEMAND FOR ADVANCED THERAPIES
12.6 CRANIAL NERVE DISORDERS
12.6.1 ADVANCES IN CRANIAL NERVE DISORDER MANAGEMENT TO CREATE GROWTH OPPORTUNITIES
12.7 UROLOGICAL & PELVIC NERVE DISORDERS
12.7.1 INCREASING AWARENESS OF NERVE-BASED TREATMENT APPROACHES TO ACCELERATE ADOPTION
12.8 ORTHOPEDIC & SPORTS-RELATED NERVE INJURIES
12.8.1 GROWING PARTICIPATION IN SPORTS AND PHYSICAL ACTIVITIES TO FUEL DEMAND FOR NERVE REPAIR SOLUTIONS
12.9 OTHER APPLICATIONS
13 NERVE REPAIR & REGENERATION MARKET, BY END USER
13.1 INTRODUCTION
13.2 HOSPITALS & AMBULATORY SURGICAL CENTERS
13.2.1 ADVANCED INFRASTRUCTURE AND ABILITY TO MANAGE COMPLEX NEUROLOGICAL CASES TO PROPEL MARKET GROWTH
13.3 SPECIALTY CLINICS
13.3.1 NEED FOR FOCUSED EXPERTISE AND BETTER REHABILITATION MANAGEMENT TO ACCELERATE MARKET EXPANSION
13.4 OTHER END USERS
14 NERVE REPAIR & REGENERATION MARKET, BY REGION
14.1 INTRODUCTION
14.2 NORTH AMERICA
14.2.1 US
14.2.1.1 US to dominate North American nerve repair & regeneration market during forecast period
14.2.2 CANADA
14.2.2.1 Increasing neurological disorder rates and rising government funding to propel market growth
14.3 EUROPE
14.3.1 GERMANY
14.3.1.1 Favorable government initiatives to boost market
14.3.2 UK
14.3.2.1 Increased public & private sector healthcare expenditure and investments to fuel market growth
14.3.3 FRANCE
14.3.3.1 Favorable healthcare reforms to drive adoption of advanced neuromodulation techniques
14.3.4 ITALY
14.3.4.1 Rising cases of dementia and Alzheimer’s among geriatric population to spur market growth
14.3.5 SPAIN
14.3.5.1 Growing geriatric population and subsequent increase in incidence of neurological disorders to drive market growth
14.3.6 REST OF EUROPE
14.4 ASIA PACIFIC
14.4.1 CHINA
14.4.1.1 Increasing focus on healthcare infrastructure to boost market
14.4.2 JAPAN
14.4.2.1 Established healthcare system to fuel market
14.4.3 INDIA
14.4.3.1 Presence of large patient pool and rapidly growing healthcare sector to drive market
14.4.4 REST OF ASIA PACIFIC
14.5 LATIN AMERICA
14.5.1 INCREASING OCCURRENCE OF NEUROLOGICAL DISORDERS ACROSS REGION TO SUPPORT GROWTH
14.6 MIDDLE EAST & AFRICA
14.6.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE AND INCREASED INVESTMENTS FROM GLOBAL AND REGIONAL MARKET PLAYERS TO FUEL GROWTH
15 COMPETITIVE LANDSCAPE
15.1 INTRODUCTION
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
15.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN NERVE REPAIR & REGENERATION MARKET
15.3 REVENUE ANALYSIS, 2023–2025
15.4 MARKET SHARE ANALYSIS, 2025
15.4.1 GLOBAL MARKET SHARE ANALYSIS, 2025
15.4.2 US MARKET SHARE ANALYSIS, 2025
15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
15.5.1 STARS
15.5.2 EMERGING LEADERS
15.5.3 PERVASIVE PLAYERS
15.5.4 PARTICIPANTS
15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
15.5.5.1 Company footprint
15.5.5.2 Region footprint
15.5.5.3 Product footprint
15.5.5.4 Procedure footprint
15.5.5.5 End-user footprint
15.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
15.6.1 PROGRESSIVE COMPANIES
15.6.2 RESPONSIVE COMPANIES
15.6.3 DYNAMIC COMPANIES
15.6.4 STARTING BLOCKS
15.6.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
15.6.5.1 Detailed list of key startups/SMEs
15.6.5.1.1 Competitive benchmarking of startups/SMEs (1/2)
15.6.5.1.2 Competitive benchmarking of startups/SMEs (2/2)
15.7 COMPANY VALUATION & FINANCIAL METRICS
15.7.1 FINANCIAL METRICS
15.7.2 COMPANY VALUATION
15.8 BRAND/PRODUCT COMPARISON
15.9 COMPETITIVE SCENARIO
15.9.1 PRODUCT LAUNCHES & APPROVALS
15.9.2 DEALS
16 COMPANY PROFILES
16.1 KEY PLAYERS
16.1.1 MEDTRONIC
16.1.1.1 Business overview
16.1.1.2 Products offered
16.1.1.3 Recent developments
16.1.1.3.1 Product approvals
16.1.1.3.2 Deals
16.1.1.4 MnM view
16.1.1.4.1 Right to win
16.1.1.4.2 Strategic choices
16.1.1.4.3 Weaknesses & competitive threats
16.1.2 BOSTON SCIENTIFIC CORPORATION
16.1.2.1 Business overview
16.1.2.2 Products offered
16.1.2.3 Recent developments
16.1.2.3.1 Product approvals
16.1.2.3.2 Deals
16.1.2.4 MnM view
16.1.2.4.1 Right to win
16.1.2.4.2 Strategic choices
16.1.2.4.3 Weaknesses & competitive threats
16.1.3 ABBOTT
16.1.3.1 Business overview
16.1.3.2 Products offered
16.1.3.3 Recent developments
16.1.3.3.1 Product approvals
16.1.3.4 MnM view
16.1.3.4.1 Right to win
16.1.3.4.2 Strategic choices
16.1.3.4.3 Weaknesses & competitive threats
16.1.4 LIVANOVA PLC
16.1.4.1 Business overview
16.1.4.2 Products offered
16.1.4.3 Recent developments
16.1.4.3.1 Product launches
16.1.4.4 MnM view
16.1.4.4.1 Right to win
16.1.4.4.2 Strategic choices
16.1.4.4.3 Weaknesses & competitive threats
16.1.5 AXOGEN CORPORATION
16.1.5.1 Business overview
16.1.5.2 Products offered
16.1.5.3 Recent developments
16.1.5.3.1 Product launches
16.1.5.4 MnM view
16.1.5.4.1 Right to win
16.1.5.4.2 Strategic choices
16.1.5.4.3 Weaknesses & competitive threats
16.1.6 NEUROPACE, INC.
16.1.6.1 Business overview
16.1.6.2 Products offered
16.1.7 BIOVENTUS
16.1.7.1 Business overview
16.1.7.2 Products offered
16.1.7.3 Recent developments
16.1.7.3.1 Product approvals
16.1.8 BAXTER
16.1.8.1 Business overview
16.1.8.2 Products offered
16.1.8.3 Recent developments
16.1.8.3.1 Deals
16.1.9 NEURONETICS
16.1.9.1 Business overview
16.1.9.2 Products offered
16.1.9.3 Recent developments
16.1.9.3.1 Product launches & approvals
16.1.9.3.2 Deals
16.1.10 INTEGRA LIFESCIENCES
16.1.10.1 Business overview
16.1.10.2 Products offered
16.1.11 ELECTROCORE, INC.
16.1.11.1 Business overview
16.1.11.2 Products offered
16.1.11.3 Recent developments
16.1.11.3.1 Product launches
16.1.11.3.2 Deals
16.2 OTHER PLAYERS
16.2.1 NEUROSIGMA, INC.
16.2.2 SOTERIX MEDICAL INC.
16.2.3 SYNAPSE BIOMEDICAL INC.
16.2.4 ALEVA NEUROTHERAPEUTICS
16.2.5 THERANICA BIO-ELECTRONICS LTD.
16.2.6 GIMER MEDICAL
16.2.7 REGENITY BIOSCIENCES
16.2.8 CHECKPOINT SURGICAL, INC.
16.2.9 RENISHAW PLC
16.2.10 TVNS TECHNOLOGIES GMBH
16.2.11 BIOWAVE
16.2.12 BIOTRONIK
16.2.13 SALUDA MEDICAL PTY LTD.
16.2.14 ALAFAIR BIOSCIENCES, INC.
17 RESEARCH METHODOLOGY
17.1 RESEARCH DATA
17.1.1 SECONDARY DATA
17.1.1.1 List of secondary sources
17.1.1.2 Key data from secondary sources
17.1.2 PRIMARY DATA
17.1.2.1 List of primary sources
17.1.2.2 Key data from primary sources
17.1.2.3 Key industry insights
17.1.2.4 Breakdown of primary interviews
17.2 MARKET SIZE ESTIMATION
17.2.1 TOTAL MARKET SIZE: NERVE REPAIR & REGENERATIVE MARKET
17.2.2 BOTTOM-UP APPROACH
17.2.2.1 Approach 1: Revenue estimation of key players
17.2.2.2 Approach 2: Study of annual reports and investor presentations
17.2.2.3 Approach 3: Primary interviews
17.2.2.4 Growth forecast
17.2.2.5 CAGR projections
17.2.3 TOP-DOWN APPROACH
17.3 DATA TRIANGULATION
17.4 RESEARCH ASSUMPTIONS
17.4.1 STUDY-RELATED ASSUMPTIONS
17.5 STUDY ASSUMPTIONS
17.6 PARAMETRIC ASSUMPTIONS
17.7 RESEARCH LIMITATIONS
17.8 RISK ASSESSMENT
18 APPENDIX
18.1 DISCUSSION GUIDE
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
18.3 CUSTOMIZATION OPTIONS
18.4 RELATED REPORTS
18.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 KEY MOVES & STRATEGIC FOCUS
TABLE 2 NERVE REPAIR & REGENERATION MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 3 GDP PERCENTAGE CHANGE (%), BY KEY COUNTRY, 2023–2030
TABLE 4 NORTH AMERICA: MACROECONOMIC INDICATORS
TABLE 5 EUROPE: MACROECONOMIC INDICATORS
TABLE 6 ASIA PACIFIC: MACROECONOMIC INDICATORS
TABLE 7 LATIN AMERICA: MACROECONOMIC INDICATORS
TABLE 8 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
TABLE 9 NERVE REPAIR & REGENERATION MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 10 AVERAGE SELLING PRICE TREND OF NERVE REPAIR & REGENERATION PRODUCTS, BY KEY PLAYER, 2024–2026 (USD)
TABLE 11 AVERAGE SELLING PRICE TREND OF NERVE REPAIR & REGENERATION PRODUCTS, BY REGION, 2024–2026 (USD)
TABLE 12 IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION)
TABLE 13 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION)
TABLE 14 NERVE REPAIR & REGENERATION MARKET: KEY CONFERENCES & EVENTS, 2026–2027
TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 16 KEY PATENTS IN NERVE REPAIR & REGENERATION MARKET, 2022–2026
TABLE 17 KEY COMPANIES IMPLEMENTING AI IN NERVE REPAIR & REGENERATION MARKET
TABLE 18 CLASSIFICATION OF MEDICAL DEVICES BY US FDA
TABLE 19 NATIONAL MEDICAL PRODUCTS ADMINISTRATION (NMPA) MEDICAL DEVICES CLASSIFICATION
TABLE 20 JAPAN: CLASSIFICATION OF MEDICAL DEVICES
TABLE 21 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%)
TABLE 27 KEY BUYING CRITERIA, BY END USER
TABLE 28 ADOPTION BARRIERS & INTERNAL CHALLENGES
TABLE 29 NERVE REPAIR & REGENERATION MARKET: UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
TABLE 30 NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 31 NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 32 SPINAL CORD STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 33 NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 34 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 35 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 36 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 37 DEEP BRAIN STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 38 NERVE REPAIR & REGENERATION MARKET FOR DEEP BRAIN STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 39 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR DEEP BRAIN STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 40 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR DEEP BRAIN STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 41 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR DEEP BRAIN STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42 VAGUS NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 43 NERVE REPAIR & REGENERATION MARKET FOR VAGUS NERVE STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 44 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR VAGUS NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR VAGUS NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 46 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR VAGUS NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 47 SACRAL NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 48 NERVE REPAIR & REGENERATION MARKET FOR SACRAL NERVE STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 49 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR SACRAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 50 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR SACRAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR SACRAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 52 GASTRIC NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 53 NERVE REPAIR & REGENERATION MARKET FOR GASTRIC NERVE STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 54 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR GASTRIC NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR GASTRIC NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 56 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR GASTRIC NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 57 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 58 NERVE REPAIR & REGENERATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 59 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 62 TRANSCRANIAL MAGNETIC STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 63 NERVE REPAIR & REGENERATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 64 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 65 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 66 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 67 RESPIRATORY ELECTRICAL STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 68 NERVE REPAIR & REGENERATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 69 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 70 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 71 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 72 OTHER STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 73 NERVE REPAIR & REGENERATION MARKET FOR OTHER STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 74 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR OTHER STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 75 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR OTHER STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 76 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR OTHER STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77 NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 78 NERVE CONDUITS OFFERED BY SOME MARKET PLAYERS
TABLE 79 NERVE REPAIR & REGENERATION MARKET FOR NERVE CONDUITS, BY REGION, 2024–2031 (USD MILLION)
TABLE 80 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE CONDUITS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 81 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE CONDUITS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 82 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE CONDUITS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 83 NERVE GRAFTS OFFERED BY SOME MARKET PLAYERS
TABLE 84 NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 85 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 86 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 87 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 88 NERVE WRAPS OFFERED BY SOME MARKET PLAYERS
TABLE 89 NERVE REPAIR & REGENERATION MARKET FOR NERVE WRAPS, BY REGION, 2024–2031 (USD MILLION)
TABLE 90 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE WRAPS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 91 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE WRAPS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 92 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE WRAPS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 93 NERVE PROTECTORS OFFERED BY SOME MARKET PLAYERS
TABLE 94 NERVE REPAIR & REGENERATION MARKET FOR NERVE PROTECTORS, BY REGION, 2024–2031 (USD MILLION)
TABLE 95 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE PROTECTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 96 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE PROTECTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 97 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE PROTECTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 98 GLOBAL NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (NUMBER OF DEVICES)
TABLE 99 NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 100 NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 101 NERVE REPAIR & REGENERATION MARKET FOR INTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY REGION, 2024–2031 (USD MILLION)
TABLE 102 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR INTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 103 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR INTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 104 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR INTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 105 NERVE REPAIR & REGENERATION MARKET FOR EXTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY REGION, 2024–2031 (USD MILLION)
TABLE 106 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR EXTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 107 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR EXTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 108 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR EXTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 109 NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 110 NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 111 NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY REGION, 2024–2031 (USD MILLION)
TABLE 112 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 113 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 114 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 115 NERVE REPAIR & REGENERATION MARKET FOR EPINEURAL REPAIR PROCEDURES, BY REGION, 2024–2031 (USD MILLION)
TABLE 116 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR EPINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 117 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR EPINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 118 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR EPINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 119 NERVE REPAIR & REGENERATION MARKET FOR PERINEURAL REPAIR PROCEDURES, BY REGION, 2024–2031 (USD MILLION)
TABLE 120 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR PERINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 121 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR PERINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 122 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR PERINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 123 NERVE REPAIR & REGENERATION MARKET FOR GROUP FASCICULAR REPAIR PROCEDURES, BY REGION, 2024–2031 (USD MILLION)
TABLE 124 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR GROUP FASCICULAR REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 125 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR GROUP FASCICULAR REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 126 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR GROUP FASCICULAR REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 127 NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 128 NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY REGION, 2024–2031 (USD MILLION)
TABLE 129 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 130 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 131 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 132 NERVE REPAIR & REGENERATION MARKET FOR ALLOGRAFTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 133 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR ALLOGRAFTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 134 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR ALLOGRAFTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 135 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR ALLOGRAFTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 136 NERVE REPAIR & REGENERATION MARKET FOR XENOGRAFTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 137 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR XENOGRAFTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 138 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR XENOGRAFTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 139 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR XENOGRAFTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 140 NERVE REPAIR & REGENERATION MARKET FOR NERVE GUIDANCE & PROTECTION PROCEDURES, BY REGION, 2024–2031 (USD MILLION)
TABLE 141 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE GUIDANCE & PROTECTION PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 142 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE GUIDANCE & PROTECTION PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 143 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE GUIDANCE & PROTECTION PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 144 NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 145 NERVE REPAIR & REGENERATION MARKET FOR PERIPHERAL NERVE INJURIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 146 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR PERIPHERAL NERVE INJURIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 147 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR PERIPHERAL NERVE INJURIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 148 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR PERIPHERAL NERVE INJURIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 149 NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD INJURIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 150 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD INJURIES, 2024–2031 (USD MILLION)
TABLE 151 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD INJURIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 152 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD INJURIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 153 NERVE REPAIR & REGENERATION MARKET FOR NEUROPATHIC PAIN, BY REGION, 2024–2031 (USD MILLION)
TABLE 154 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROPATHIC PAIN, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 155 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEUROPATHIC PAIN, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 156 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NEUROPATHIC PAIN, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 157 NERVE REPAIR & REGENERATION MARKET FOR NEURODEGENERATIVE DISORDERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 158 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEURODEGENERATIVE DISORDERS, 2024–2031 (USD MILLION)
TABLE 159 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEURODEGENERATIVE DISORDERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 160 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NEURODEGENERATIVE DISORDERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 161 NERVE REPAIR & REGENERATION MARKET FOR CRANIAL NERVE DISORDERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 162 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR CRANIAL NERVE DISORDERS, 2024–2031 (USD MILLION)
TABLE 163 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR CRANIAL NERVE DISORDERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 164 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR CRANIAL NERVE DISORDERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 165 NERVE REPAIR & REGENERATION MARKET FOR UROLOGICAL & PELVIC NERVE DISORDERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 166 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR UROLOGICAL & PELVIC NERVE DISORDERS, 2024–2031 (USD MILLION)
TABLE 167 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR UROLOGICAL & PELVIC NERVE DISORDERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 168 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR UROLOGICAL & PELVIC NERVE DISORDERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 169 NERVE REPAIR & REGENERATION MARKET FOR ORTHOPEDIC & SPORTS-RELATED NERVE INJURIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 170 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR ORTHOPEDIC & SPORTS-RELATED NERVE INJURIES, 2024–2031 (USD MILLION)
TABLE 171 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR ORTHOPEDIC & SPORTS-RELATED NERVE INJURIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 172 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR ORTHOPEDIC & SPORTS-RELATED NERVE INJURIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 173 NERVE REPAIR & REGENERATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 174 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR OTHER APPLICATIONS, 2024–2031 (USD MILLION)
TABLE 175 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 176 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 177 NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 178 NUMBER OF HOSPITALS PER CAPITA, BY COUNTRY, 2026
TABLE 179 NERVE REPAIR & REGENERATION MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 180 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 181 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 182 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 183 NERVE REPAIR & REGENERATION MARKET FOR SPECIALTY CLINICS, BY REGION, 2024–2031 (USD MILLION)
TABLE 184 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 185 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 186 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 187 NERVE REPAIR & REGENERATION MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 188 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR OTHER END USERS, 2024–2031 (USD MILLION)
TABLE 189 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 190 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 191 NERVE REPAIR & REGENERATION MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 192 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 193 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 194 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 195 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 196 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 197 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 198 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 199 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 200 NORTH AMERICA: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 201 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 202 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 203 COMPANY PRODUCTS THAT RECEIVED APPROVAL IN US
TABLE 204 US: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 205 US: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 206 US: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 207 US: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 208 US: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 209 US: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 210 US: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 211 US: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 212 US: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 213 US: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 214 CANADA: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 215 CANADA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 216 CANADA: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 217 CANADA: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 218 CANADA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 219 CANADA: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 220 CANADA: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 221 CANADA: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 222 CANADA: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 223 CANADA: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 224 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 225 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 226 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 227 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 228 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 229 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 230 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 231 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 232 EUROPE: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 233 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 234 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 235 GERMANY: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 236 GERMANY: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 237 GERMANY: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 238 GERMANY: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 239 GERMANY: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 240 GERMANY: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 241 GERMANY: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 242 GERMANY: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 243 GERMANY: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 244 GERMANY: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 245 UK: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 246 UK: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 247 UK: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 248 UK: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 249 UK: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 250 UK: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 251 UK: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 252 UK: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 253 UK: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 254 UK: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 255 FRANCE: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 256 FRANCE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 257 FRANCE: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 258 FRANCE: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 259 FRANCE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 260 FRANCE: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 261 FRANCE: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 262 FRANCE: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 263 FRANCE: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 264 FRANCE: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 265 ITALY: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 266 ITALY: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 267 ITALY: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 268 ITALY: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 269 ITALY: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 270 ITALY: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 271 ITALY: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 272 ITALY: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 273 ITALY: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 274 ITALY: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 275 SPAIN: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 276 SPAIN: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 277 SPAIN: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 278 SPAIN: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 279 SPAIN: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 280 SPAIN: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 281 SPAIN: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 282 SPAIN: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 283 SPAIN: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 284 SPAIN: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 285 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 286 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 287 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 288 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 289 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 290 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 291 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 292 REST OF EUROPE: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 1 KEY MOVES & STRATEGIC FOCUS
TABLE 2 NERVE REPAIR & REGENERATION MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 3 GDP PERCENTAGE CHANGE (%), BY KEY COUNTRY, 2023–2030
TABLE 4 NORTH AMERICA: MACROECONOMIC INDICATORS
TABLE 5 EUROPE: MACROECONOMIC INDICATORS
TABLE 6 ASIA PACIFIC: MACROECONOMIC INDICATORS
TABLE 7 LATIN AMERICA: MACROECONOMIC INDICATORS
TABLE 8 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
TABLE 9 NERVE REPAIR & REGENERATION MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 10 AVERAGE SELLING PRICE TREND OF NERVE REPAIR & REGENERATION PRODUCTS, BY KEY PLAYER, 2024–2026 (USD)
TABLE 11 AVERAGE SELLING PRICE TREND OF NERVE REPAIR & REGENERATION PRODUCTS, BY REGION, 2024–2026 (USD)
TABLE 12 IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION)
TABLE 13 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION)
TABLE 14 NERVE REPAIR & REGENERATION MARKET: KEY CONFERENCES & EVENTS, 2026–2027
TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 16 KEY PATENTS IN NERVE REPAIR & REGENERATION MARKET, 2022–2026
TABLE 17 KEY COMPANIES IMPLEMENTING AI IN NERVE REPAIR & REGENERATION MARKET
TABLE 18 CLASSIFICATION OF MEDICAL DEVICES BY US FDA
TABLE 19 NATIONAL MEDICAL PRODUCTS ADMINISTRATION (NMPA) MEDICAL DEVICES CLASSIFICATION
TABLE 20 JAPAN: CLASSIFICATION OF MEDICAL DEVICES
TABLE 21 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%)
TABLE 27 KEY BUYING CRITERIA, BY END USER
TABLE 28 ADOPTION BARRIERS & INTERNAL CHALLENGES
TABLE 29 NERVE REPAIR & REGENERATION MARKET: UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
TABLE 30 NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 31 NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 32 SPINAL CORD STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 33 NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 34 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 35 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 36 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 37 DEEP BRAIN STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 38 NERVE REPAIR & REGENERATION MARKET FOR DEEP BRAIN STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 39 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR DEEP BRAIN STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 40 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR DEEP BRAIN STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 41 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR DEEP BRAIN STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42 VAGUS NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 43 NERVE REPAIR & REGENERATION MARKET FOR VAGUS NERVE STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 44 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR VAGUS NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR VAGUS NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 46 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR VAGUS NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 47 SACRAL NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 48 NERVE REPAIR & REGENERATION MARKET FOR SACRAL NERVE STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 49 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR SACRAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 50 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR SACRAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR SACRAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 52 GASTRIC NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 53 NERVE REPAIR & REGENERATION MARKET FOR GASTRIC NERVE STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 54 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR GASTRIC NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR GASTRIC NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 56 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR GASTRIC NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 57 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 58 NERVE REPAIR & REGENERATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 59 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 62 TRANSCRANIAL MAGNETIC STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 63 NERVE REPAIR & REGENERATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 64 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 65 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 66 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 67 RESPIRATORY ELECTRICAL STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 68 NERVE REPAIR & REGENERATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 69 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 70 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 71 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 72 OTHER STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 73 NERVE REPAIR & REGENERATION MARKET FOR OTHER STIMULATION DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 74 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR OTHER STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 75 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR OTHER STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 76 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR OTHER STIMULATION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77 NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 78 NERVE CONDUITS OFFERED BY SOME MARKET PLAYERS
TABLE 79 NERVE REPAIR & REGENERATION MARKET FOR NERVE CONDUITS, BY REGION, 2024–2031 (USD MILLION)
TABLE 80 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE CONDUITS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 81 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE CONDUITS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 82 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE CONDUITS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 83 NERVE GRAFTS OFFERED BY SOME MARKET PLAYERS
TABLE 84 NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 85 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 86 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 87 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 88 NERVE WRAPS OFFERED BY SOME MARKET PLAYERS
TABLE 89 NERVE REPAIR & REGENERATION MARKET FOR NERVE WRAPS, BY REGION, 2024–2031 (USD MILLION)
TABLE 90 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE WRAPS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 91 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE WRAPS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 92 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE WRAPS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 93 NERVE PROTECTORS OFFERED BY SOME MARKET PLAYERS
TABLE 94 NERVE REPAIR & REGENERATION MARKET FOR NERVE PROTECTORS, BY REGION, 2024–2031 (USD MILLION)
TABLE 95 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE PROTECTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 96 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE PROTECTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 97 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE PROTECTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 98 GLOBAL NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (NUMBER OF DEVICES)
TABLE 99 NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 100 NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 101 NERVE REPAIR & REGENERATION MARKET FOR INTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY REGION, 2024–2031 (USD MILLION)
TABLE 102 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR INTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 103 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR INTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 104 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR INTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 105 NERVE REPAIR & REGENERATION MARKET FOR EXTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY REGION, 2024–2031 (USD MILLION)
TABLE 106 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR EXTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 107 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR EXTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 108 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR EXTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 109 NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 110 NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 111 NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY REGION, 2024–2031 (USD MILLION)
TABLE 112 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 113 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 114 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 115 NERVE REPAIR & REGENERATION MARKET FOR EPINEURAL REPAIR PROCEDURES, BY REGION, 2024–2031 (USD MILLION)
TABLE 116 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR EPINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 117 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR EPINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 118 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR EPINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 119 NERVE REPAIR & REGENERATION MARKET FOR PERINEURAL REPAIR PROCEDURES, BY REGION, 2024–2031 (USD MILLION)
TABLE 120 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR PERINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 121 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR PERINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 122 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR PERINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 123 NERVE REPAIR & REGENERATION MARKET FOR GROUP FASCICULAR REPAIR PROCEDURES, BY REGION, 2024–2031 (USD MILLION)
TABLE 124 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR GROUP FASCICULAR REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 125 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR GROUP FASCICULAR REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 126 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR GROUP FASCICULAR REPAIR PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 127 NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 128 NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY REGION, 2024–2031 (USD MILLION)
TABLE 129 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 130 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 131 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 132 NERVE REPAIR & REGENERATION MARKET FOR ALLOGRAFTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 133 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR ALLOGRAFTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 134 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR ALLOGRAFTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 135 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR ALLOGRAFTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 136 NERVE REPAIR & REGENERATION MARKET FOR XENOGRAFTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 137 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR XENOGRAFTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 138 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR XENOGRAFTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 139 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR XENOGRAFTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 140 NERVE REPAIR & REGENERATION MARKET FOR NERVE GUIDANCE & PROTECTION PROCEDURES, BY REGION, 2024–2031 (USD MILLION)
TABLE 141 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE GUIDANCE & PROTECTION PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 142 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE GUIDANCE & PROTECTION PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 143 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE GUIDANCE & PROTECTION PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 144 NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 145 NERVE REPAIR & REGENERATION MARKET FOR PERIPHERAL NERVE INJURIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 146 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR PERIPHERAL NERVE INJURIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 147 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR PERIPHERAL NERVE INJURIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 148 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR PERIPHERAL NERVE INJURIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 149 NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD INJURIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 150 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD INJURIES, 2024–2031 (USD MILLION)
TABLE 151 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD INJURIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 152 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD INJURIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 153 NERVE REPAIR & REGENERATION MARKET FOR NEUROPATHIC PAIN, BY REGION, 2024–2031 (USD MILLION)
TABLE 154 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROPATHIC PAIN, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 155 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEUROPATHIC PAIN, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 156 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NEUROPATHIC PAIN, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 157 NERVE REPAIR & REGENERATION MARKET FOR NEURODEGENERATIVE DISORDERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 158 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEURODEGENERATIVE DISORDERS, 2024–2031 (USD MILLION)
TABLE 159 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEURODEGENERATIVE DISORDERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 160 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NEURODEGENERATIVE DISORDERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 161 NERVE REPAIR & REGENERATION MARKET FOR CRANIAL NERVE DISORDERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 162 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR CRANIAL NERVE DISORDERS, 2024–2031 (USD MILLION)
TABLE 163 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR CRANIAL NERVE DISORDERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 164 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR CRANIAL NERVE DISORDERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 165 NERVE REPAIR & REGENERATION MARKET FOR UROLOGICAL & PELVIC NERVE DISORDERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 166 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR UROLOGICAL & PELVIC NERVE DISORDERS, 2024–2031 (USD MILLION)
TABLE 167 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR UROLOGICAL & PELVIC NERVE DISORDERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 168 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR UROLOGICAL & PELVIC NERVE DISORDERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 169 NERVE REPAIR & REGENERATION MARKET FOR ORTHOPEDIC & SPORTS-RELATED NERVE INJURIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 170 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR ORTHOPEDIC & SPORTS-RELATED NERVE INJURIES, 2024–2031 (USD MILLION)
TABLE 171 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR ORTHOPEDIC & SPORTS-RELATED NERVE INJURIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 172 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR ORTHOPEDIC & SPORTS-RELATED NERVE INJURIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 173 NERVE REPAIR & REGENERATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 174 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR OTHER APPLICATIONS, 2024–2031 (USD MILLION)
TABLE 175 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 176 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 177 NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 178 NUMBER OF HOSPITALS PER CAPITA, BY COUNTRY, 2026
TABLE 179 NERVE REPAIR & REGENERATION MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 180 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 181 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 182 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 183 NERVE REPAIR & REGENERATION MARKET FOR SPECIALTY CLINICS, BY REGION, 2024–2031 (USD MILLION)
TABLE 184 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 185 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 186 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 187 NERVE REPAIR & REGENERATION MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 188 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR OTHER END USERS, 2024–2031 (USD MILLION)
TABLE 189 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 190 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 191 NERVE REPAIR & REGENERATION MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 192 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 193 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 194 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 195 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 196 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 197 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 198 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 199 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 200 NORTH AMERICA: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 201 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 202 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 203 COMPANY PRODUCTS THAT RECEIVED APPROVAL IN US
TABLE 204 US: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 205 US: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 206 US: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 207 US: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 208 US: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 209 US: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 210 US: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 211 US: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 212 US: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 213 US: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 214 CANADA: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 215 CANADA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 216 CANADA: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 217 CANADA: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 218 CANADA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 219 CANADA: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 220 CANADA: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 221 CANADA: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 222 CANADA: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 223 CANADA: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 224 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 225 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 226 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 227 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 228 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 229 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 230 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 231 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 232 EUROPE: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 233 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 234 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 235 GERMANY: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 236 GERMANY: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 237 GERMANY: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 238 GERMANY: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 239 GERMANY: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 240 GERMANY: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 241 GERMANY: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 242 GERMANY: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 243 GERMANY: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 244 GERMANY: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 245 UK: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 246 UK: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 247 UK: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 248 UK: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 249 UK: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 250 UK: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 251 UK: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 252 UK: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 253 UK: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 254 UK: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 255 FRANCE: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 256 FRANCE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 257 FRANCE: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 258 FRANCE: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 259 FRANCE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 260 FRANCE: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 261 FRANCE: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 262 FRANCE: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 263 FRANCE: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 264 FRANCE: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 265 ITALY: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 266 ITALY: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 267 ITALY: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 268 ITALY: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 269 ITALY: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 270 ITALY: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 271 ITALY: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 272 ITALY: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 273 ITALY: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 274 ITALY: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 275 SPAIN: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 276 SPAIN: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 277 SPAIN: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 278 SPAIN: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 279 SPAIN: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 280 SPAIN: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 281 SPAIN: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 282 SPAIN: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 283 SPAIN: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 284 SPAIN: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 285 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 286 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 287 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 288 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
TABLE 289 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 290 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 291 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 292 REST OF EUROPE: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024–2031 (USD MILLION)
LIST OF FIGURES
FIGURE 1 NERVE REPAIR & REGENERATION MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2 KEY INSIGHTS & MARKET HIGHLIGHTS
FIGURE 3 GLOBAL NERVE REPAIR & REGENERATION MARKET, 2024–2031
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NERVE REPAIR & REGENERATION MARKET, 2023–2025
FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF NERVE REPAIR & REGENERATION MARKET
FIGURE 6 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN NERVE REPAIR & REGENERATION MARKET, 2025
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 8 RISING CASES OF NEUROLOGICAL DISEASES TO DRIVE MARKET GROWTH DURING FORECAST PERIOD
FIGURE 9 NEUROSTIMULATION & NEUROMODULATION DEVICES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 10 NEUROSTIMULATION & NEUROMODULATION PROCEDURES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 11 PERIPHERAL NERVE INJURIES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 12 HOSPITALS & ASCS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 13 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 14 NERVE REPAIR & REGENERATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15 NERVE REPAIR & REGENERATION MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 16 NERVE REPAIR & REGENERATION MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 17 NERVE REPAIR & REGENERATION MARKET: VALUE CHAIN ANALYSIS
FIGURE 18 NERVE REPAIR & REGENERATION MARKET: ECOSYSTEM ANALYSIS
FIGURE 19 NERVE REPAIR & REGENERATION MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 20 NUMBER OF DEALS & FUNDING ACTIVITIES IN NERVE REPAIR & REGENERATION MARKET
FIGURE 21 PATENT ANALYSIS FOR NERVE REPAIR & REGENERATION, JANUARY 2016–DECEMBER 2025
FIGURE 22 MARKET POTENTIAL OF AI IN NERVE REPAIR & REGENERATION MARKET
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
FIGURE 24 KEY BUYING CRITERIA, BY END USER
FIGURE 25 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET SNAPSHOT
FIGURE 26 NUMBER OF PATIENTS WITH ALZHEIMER’S IN US, 2020–2060 (MILLION)
FIGURE 27 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET SNAPSHOT
FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN NERVE REPAIR & REGENERATION MARKET, 2023–2025 (USD MILLION)
FIGURE 29 NERVE REPAIR & REGENERATION MARKET SHARE ANALYSIS, 2025 (GLOBAL)
FIGURE 30 NERVE REPAIR & REGENERATION MARKET SHARE ANALYSIS, 2025 (US)
FIGURE 31 NERVE REPAIR & REGENERATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 32 NERVE REPAIR & REGENERATION MARKET: COMPANY FOOTPRINT
FIGURE 33 NERVE REPAIR & REGENERATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 34 EV/EBITDA OF KEY VENDORS
FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 36 NERVE REPAIR & REGENERATION MARKET: BRAND/PRODUCT COMPARISON FOR NERVE REPAIR & REGENERATION
FIGURE 37 MEDTRONIC: COMPANY SNAPSHOT (2025)
FIGURE 38 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 39 ABBOTT: COMPANY SNAPSHOT (2025)
FIGURE 40 LIVANOVA PLC: COMPANY SNAPSHOT (2025)
FIGURE 41 AXOGEN CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 42 NEUROPACE, INC.: COMPANY SNAPSHOT
FIGURE 43 BIOVENTUS: COMPANY SNAPSHOT (2025)
FIGURE 44 BAXTER: COMPANY SNAPSHOT (2025)
FIGURE 45 NEURONETICS: COMPANY SNAPSHOT (2025)
FIGURE 46 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2025)
FIGURE 47 ELECTROCORE, INC.: COMPANY SNAPSHOT (2024)
FIGURE 48 RESEARCH DESIGN
FIGURE 49 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 50 TOP-DOWN APPROACH
FIGURE 51 DATA TRIANGULATION
FIGURE 1 NERVE REPAIR & REGENERATION MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2 KEY INSIGHTS & MARKET HIGHLIGHTS
FIGURE 3 GLOBAL NERVE REPAIR & REGENERATION MARKET, 2024–2031
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NERVE REPAIR & REGENERATION MARKET, 2023–2025
FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF NERVE REPAIR & REGENERATION MARKET
FIGURE 6 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN NERVE REPAIR & REGENERATION MARKET, 2025
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 8 RISING CASES OF NEUROLOGICAL DISEASES TO DRIVE MARKET GROWTH DURING FORECAST PERIOD
FIGURE 9 NEUROSTIMULATION & NEUROMODULATION DEVICES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 10 NEUROSTIMULATION & NEUROMODULATION PROCEDURES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 11 PERIPHERAL NERVE INJURIES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 12 HOSPITALS & ASCS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 13 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 14 NERVE REPAIR & REGENERATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15 NERVE REPAIR & REGENERATION MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 16 NERVE REPAIR & REGENERATION MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 17 NERVE REPAIR & REGENERATION MARKET: VALUE CHAIN ANALYSIS
FIGURE 18 NERVE REPAIR & REGENERATION MARKET: ECOSYSTEM ANALYSIS
FIGURE 19 NERVE REPAIR & REGENERATION MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 20 NUMBER OF DEALS & FUNDING ACTIVITIES IN NERVE REPAIR & REGENERATION MARKET
FIGURE 21 PATENT ANALYSIS FOR NERVE REPAIR & REGENERATION, JANUARY 2016–DECEMBER 2025
FIGURE 22 MARKET POTENTIAL OF AI IN NERVE REPAIR & REGENERATION MARKET
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
FIGURE 24 KEY BUYING CRITERIA, BY END USER
FIGURE 25 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET SNAPSHOT
FIGURE 26 NUMBER OF PATIENTS WITH ALZHEIMER’S IN US, 2020–2060 (MILLION)
FIGURE 27 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET SNAPSHOT
FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN NERVE REPAIR & REGENERATION MARKET, 2023–2025 (USD MILLION)
FIGURE 29 NERVE REPAIR & REGENERATION MARKET SHARE ANALYSIS, 2025 (GLOBAL)
FIGURE 30 NERVE REPAIR & REGENERATION MARKET SHARE ANALYSIS, 2025 (US)
FIGURE 31 NERVE REPAIR & REGENERATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 32 NERVE REPAIR & REGENERATION MARKET: COMPANY FOOTPRINT
FIGURE 33 NERVE REPAIR & REGENERATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 34 EV/EBITDA OF KEY VENDORS
FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 36 NERVE REPAIR & REGENERATION MARKET: BRAND/PRODUCT COMPARISON FOR NERVE REPAIR & REGENERATION
FIGURE 37 MEDTRONIC: COMPANY SNAPSHOT (2025)
FIGURE 38 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 39 ABBOTT: COMPANY SNAPSHOT (2025)
FIGURE 40 LIVANOVA PLC: COMPANY SNAPSHOT (2025)
FIGURE 41 AXOGEN CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 42 NEUROPACE, INC.: COMPANY SNAPSHOT
FIGURE 43 BIOVENTUS: COMPANY SNAPSHOT (2025)
FIGURE 44 BAXTER: COMPANY SNAPSHOT (2025)
FIGURE 45 NEURONETICS: COMPANY SNAPSHOT (2025)
FIGURE 46 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2025)
FIGURE 47 ELECTROCORE, INC.: COMPANY SNAPSHOT (2024)
FIGURE 48 RESEARCH DESIGN
FIGURE 49 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 50 TOP-DOWN APPROACH
FIGURE 51 DATA TRIANGULATION
